Natco Pharma acquires 40 million shares in eGenesis Inc

Natco Pharma's Canadian subsidiary has acquired 40 million shares in eGenesis Inc. for USD 8 million. eGenesis is a biotechnology company developing human-compatible organs for transplant through xenotransplantation. This investment aims to support eGenesis' pioneering work in kidney, liver, and heart transplants, potentially addressing the global transplant shortage.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/0X8Lkc5
via IFTTT